# Hangzhou NeuroPeptide Biological Science and Technology Incorporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hangzhou-neuropeptide-biological-science-and-technology-inco

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Website: www.nuptec.com
- Latest round: Series A (Apr 9, 2022)
- Investors on record: 3

## About

Established in 2009 and based in Hangzhou, China, Hangzhou NeuroPeptide Biological Science and Technology Incorporation, Ltd. operates as a protein purification filler service provider. The company awarded as "National High-Tech Enterprise", "The top 100 most growing technology company" and "Rishang Province Science and Technology Enterprise". The company passed ISO9001 quality management system certification.

The company provides active protein and polypeptide products for many fields such as separation and purification of protein drugs, diagnostic reagents and cell culture. The company's products include protein, chromato, affinity filer and pre-activated filer. Protein products include NRPA33 r-SA2, NRPA34 r-SA3 and NRPA35 r-cSA3. Affinity filer products include NRPB44 Biotin NUPharose FF, NRPB60 ee-SA NUPharose FF and NRPB76L IMAC NUPharose FF. The business of company includes R&D, production and sale of bioactive protein, peptide biologics and bioseparation materials.

The company will put the funding towards product R&D and optimization, talent introduction and production base construction in series A funding.

## Funding rounds

- Series A, Apr 9, 2022 — Efung Capital, HJ Investment, Hangzhou Aopeng Investment Management

## Investors

- Efung Capital (https://capitalatlas.ai/funds/efung-capital) — Series A
- HJ Investment (https://capitalatlas.ai/funds/hj-investment) — Series A
- Hangzhou Aopeng Investment Management (https://capitalatlas.ai/funds/hangzhou-aopeng-investment-management) — Series A